|
Blue Sail Medical Co., Ltd. (002382.sz) DCF -Bewertung
CN | Healthcare | Medical - Instruments & Supplies | SHZ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Blue Sail Medical Co.,Ltd. (002382.SZ) Bundle
Optimieren Sie Ihre Analyse und verbessern Sie die Präzision mit unserem DCF -Taschenrechner (002382SZ)! Mit tatsächlichen Daten von Blue Sail Medical Co., Ltd. und anpassbaren Annahmen ermöglichen dieses Tool Sie, Blue Sail Medical wie ein erfahrener Investor zu prognostizieren, zu analysieren und zu bewerten.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3,475.6 | 7,869.4 | 8,108.6 | 4,900.5 | 4,927.1 | 5,655.0 | 6,490.5 | 7,449.3 | 8,549.9 | 9,813.0 |
| Revenue Growth, % | 0 | 126.42 | 3.04 | -39.56 | 0.54275 | 14.77 | 14.77 | 14.77 | 14.77 | 14.77 |
| EBITDA | 811.2 | 2,410.5 | 1,849.4 | 292.1 | 132.7 | 966.3 | 1,109.0 | 1,272.8 | 1,460.9 | 1,676.7 |
| EBITDA, % | 23.34 | 30.63 | 22.81 | 5.96 | 2.69 | 17.09 | 17.09 | 17.09 | 17.09 | 17.09 |
| Depreciation | 198.0 | 229.8 | 366.7 | 540.4 | 575.4 | 405.4 | 465.3 | 534.1 | 613.0 | 703.5 |
| Depreciation, % | 5.7 | 2.92 | 4.52 | 11.03 | 11.68 | 7.17 | 7.17 | 7.17 | 7.17 | 7.17 |
| EBIT | 613.2 | 2,180.8 | 1,482.7 | -248.4 | -442.7 | 560.8 | 643.7 | 738.8 | 847.9 | 973.2 |
| EBIT, % | 17.64 | 27.71 | 18.29 | -5.07 | -8.98 | 9.92 | 9.92 | 9.92 | 9.92 | 9.92 |
| Total Cash | 2,245.6 | 4,815.3 | 3,485.1 | 2,525.4 | 1,590.1 | 2,856.8 | 3,278.8 | 3,763.2 | 4,319.2 | 4,957.3 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 687.9 | 1,064.4 | 817.2 | 721.9 | 897.3 | 863.4 | 991.0 | 1,137.4 | 1,305.4 | 1,498.2 |
| Account Receivables, % | 19.79 | 13.53 | 10.08 | 14.73 | 18.21 | 15.27 | 15.27 | 15.27 | 15.27 | 15.27 |
| Inventories | 416.0 | 768.8 | 1,124.5 | 916.8 | 1,054.5 | 856.4 | 982.9 | 1,128.1 | 1,294.7 | 1,486.0 |
| Inventories, % | 11.97 | 9.77 | 13.87 | 18.71 | 21.4 | 15.14 | 15.14 | 15.14 | 15.14 | 15.14 |
| Accounts Payable | 431.9 | 785.3 | 464.5 | 266.8 | 431.0 | 478.7 | 549.4 | 630.6 | 723.8 | 830.7 |
| Accounts Payable, % | 12.43 | 9.98 | 5.73 | 5.44 | 8.75 | 8.47 | 8.47 | 8.47 | 8.47 | 8.47 |
| Capital Expenditure | -356.7 | -1,203.1 | -2,581.8 | -896.9 | -774.1 | -1,033.8 | -1,186.5 | -1,361.8 | -1,563.0 | -1,793.9 |
| Capital Expenditure, % | -10.26 | -15.29 | -31.84 | -18.3 | -15.71 | -18.28 | -18.28 | -18.28 | -18.28 | -18.28 |
| Tax Rate, % | 8.71 | 8.71 | 8.71 | 8.71 | 8.71 | 8.71 | 8.71 | 8.71 | 8.71 | 8.71 |
| EBITAT | 521.7 | 1,899.9 | 1,271.8 | -227.8 | -404.1 | 494.7 | 567.7 | 651.6 | 747.9 | 858.4 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -309.1 | 550.8 | -1,372.7 | -478.8 | -751.8 | 146.0 | -336.8 | -386.6 | -443.7 | -509.2 |
| WACC, % | 6.76 | 6.81 | 6.78 | 6.92 | 6.91 | 6.84 | 6.84 | 6.84 | 6.84 | 6.84 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1,181.9 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | -530 | |||||||||
| Terminal Value | -18,672 | |||||||||
| Present Terminal Value | -13,415 | |||||||||
| Enterprise Value | -14,597 | |||||||||
| Net Debt | 1,087 | |||||||||
| Equity Value | -15,684 | |||||||||
| Diluted Shares Outstanding, MM | 997 | |||||||||
| Equity Value Per Share | -15.73 |
What You Will Receive
- Customizable Excel Template: A fully adaptable Excel-based DCF Calculator featuring pre-populated financial data for Blue Sail Medical Co., Ltd. (002382SZ).
- Accurate Data: Access to historical figures and future estimates (displayed in the highlighted cells).
- Flexible Forecasting: Adjust forecast parameters such as revenue growth, EBITDA margin, and WACC.
- Instant Calculations: Quickly observe how your inputs affect the valuation of Blue Sail Medical Co., Ltd. (002382SZ).
- Professional Resource: Designed for investors, CFOs, consultants, and financial analysts.
- Intuitive Interface: Organized for straightforward navigation and usability, complete with step-by-step guidance.
Key Features
- Customizable Forecast Parameters: Adjust essential inputs such as revenue growth, EBITDA percentage, and capital expenditures.
- Instant DCF Valuation: Automatically determines intrinsic value, NPV, and other key metrics in real time.
- High-Precision Accuracy: Leverages Blue Sail Medical's actual financial data for credible valuation results.
- Simplified Scenario Analysis: Effortlessly evaluate various assumptions and analyze the resulting outcomes.
- Efficiency Boost: Avoid the hassle of constructing intricate valuation models from the ground up.
How It Works
- Download: Obtain the pre-configured Excel file containing financial data for Blue Sail Medical Co.,Ltd. (002382SZ).
- Customize: Tailor projections by modifying factors such as revenue growth, EBITDA %, and WACC.
- Update Automatically: Watch as intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Develop various forecasts and analyze different outcomes immediately.
- Make Decisions: Leverage the valuation insights to inform your investment approach.
Why Select This Calculator for Blue Sail Medical Co., Ltd. (002382SZ)?
- Designed for Experts: A sophisticated tool trusted by financial analysts, CFOs, and industry consultants.
- Accurate Financial Data: Comprehensive historical and projected financials for Blue Sail Medical preloaded for precision.
- Flexible Scenario Analysis: Easily test various forecasts and underlying assumptions.
- Transparent Results: Instantly computes intrinsic value, NPV, and important financial metrics.
- User-Friendly: Detailed step-by-step guidance ensures a smooth navigation through the calculations.
Who Can Benefit from Blue Sail Medical's Solutions?
- Healthcare Investors: Make informed investment choices with our comprehensive assessment tools.
- Medical Analysts: Streamline your work with our customizable financial models tailored for the healthcare sector.
- Consultants: Effortlessly modify our templates for client pitches or detailed reports.
- Healthcare Enthusiasts: Enhance your grasp of medical industry trends through real-world applications.
- Instructors and Students: Leverage our resources as effective learning aids in healthcare finance courses.
Contents of the Template
- Pre-Filled DCF Model: Blue Sail Medical's financial data preloaded for immediate analysis.
- WACC Calculator: Comprehensive calculations for the Weighted Average Cost of Capital.
- Financial Ratios: Assess Blue Sail Medical's profitability, leverage, and operational efficiency.
- Editable Inputs: Modify assumptions like growth rates, profit margins, and CAPEX to suit your scenarios.
- Financial Statements: Access annual and quarterly reports to facilitate thorough examination.
- Interactive Dashboard: Easily visualize essential valuation metrics and outcomes.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.